October 2021

The Central Government has revoked the export ban from Covid diagnostic kits, reagents by making amendment in the export policy of diagnostic kits.

The export restriction is lifted from VTM kits and reagents, RNA extraction kits, RT PCR kits, facon tube or cryovials, swabs sterile synthetic fibre etc. It also includes Silicon columns, Carrier RNA, Proteinase K, Magnetic Stand, Beads, Probes from COVID19 testing, primers for COVID testing, Taq polymerase enzyme, COVID19 rapid antigen testing kits.

Availability of injectable insulin formulation has been a major breakthrough in diabetes management. However, insulin needs to be kept in a refrigerator, which, otherwise after some hours becomes unfit for use due to fibrillation (some kind of ‘solidification’). Its prolonged storage even in normal refrigerator is also not good. Therefore, its thermal instability and fibrillation at non-refrigerated temperatures demands storage and maintenance of cold chain, making it expensive.

Dr. Reddys Laboratories Ltd announced the final approval of its Abbreviated New Drug Application (ANDA) for Lenalidomide Capsules, in 2.5 mg and 20 mg strengths, and tentative approval for 5 mg, 10 mg, 15 mg, and 25 mg strengths, a therapeutic equivalent generic version of REVLIMID® (lenalidomide) Capsules, from the U.S. Food and Drug Administration (USFDA). With this approval, Dr. Reddy’s is eligible for 180 days of generic drug exclusivity for Lenalidomide Capsules, 2.5 mg and 20 mg.

The Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad is a premier autonomous R & D Institute funded by the Department of Biotechnology, Ministry of Science and Technology, Government of India, that has been established to provide services and to undertake R & D in DNA Fingerprinting, DNA Diagnostics and other areas of modern biology.

CDFD wishes to hire a Consultant for Animal BSL – 3 Facility ( full time basis ) whose tenure is initially for one year and likely to be extended on need basis.

Kerala State Drugs & Pharmaceuticals Ltd., a Public Sector Undertaking, since its inception in 1974 has been manufacturing and supplying essential and life saving medicines to cater the need of the common patients resorting to Government Hospitals in the State of Kerala.

WHO is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends.

Post : Regional Adviser (Disability & Inj. Prev. & Rehab) - (2104493)

National Institute of Pharmaceutical Education & Research, Guwahati is an autonomous institute of National importance and the first national pharma institute in NE India set up by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India by an act of parliament, to impart high quality Education & Research in the area of Pharmaceutical Sciences.

The Institute intents to fill the following Project positions in various sponsored projects through on-line interview.

Malabar Cancer Centre, Thalassery is an autonomous institution under Health and Family Welfare Department, Government of Kerala, started with an aim to establish a comprehensive cancer centre, providing the much-required oncology care to the population of Northern region of Kerala and neighbouring parts of Karnataka and Tamilnadu states.

FIXED TERM CONTRACT BASIS IN MALABAR CANCER CENTRE

USP is proud to be an equal opportunity/affirmative action employer. Employment selection and related decisions are made without regard to sex, gender identity, race, age, disability, religion, national origin, color, veteran status or any other protected class. We are committed to working with and providing reasonable accommodation to individuals with disabilities.

Post : Scientist I